Literature DB >> 7236079

CSF findings in primary lymphoma of the CNS.

M Matsuda, H McMurria, P VanHale, C A Miller.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 7236079     DOI: 10.1001/archneur.1981.00510060099027

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  7 in total

1.  Primary malignant lymphoma of the brain: an immunohistochemical study of eight cases using a panel of monoclonal and heterologous antibodies.

Authors:  T Kumanishi; K Washiyama; T Saito; A Nishiyama; S Abe; T Tanaka
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Immunophenotypic profile of CNS lymphoma: a review of eighteen cases.

Authors:  R Bashir; A Freedman; N Harris; K Bain; L Nadler; F Hochberg
Journal:  J Neurooncol       Date:  1989-09       Impact factor: 4.130

Review 3.  Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification.

Authors:  C Vital; A Vital; J Julien; J Rivel; A deMascarel; B Vergier; P Henry; M Barat; J Reiffers; A Broustet
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

4.  Immunoblastic sarcoma of the B-cell type in the CSF. Light- and electronmicroscopic study of the malignant cells and unusual macrophages.

Authors:  S Pelc; P Fondu; J Otten; C Gompel
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

Review 5.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Primary central nervous system lymphoma: a role for adjuvant chemotherapy.

Authors:  M C Chamberlain; V A Levin
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

7.  T-cell Lymphoma Presenting Neutrophilic Inflammation in the Cerebrospinal Fluid.

Authors:  Takaaki Nakamura; Yoshiki Takai; Kimihiko Kaneko; Hiroshi Kuroda; Tatsuro Misu; Kiyotaka Asanuma; Ryoko Saito; Masashi Aoki
Journal:  Intern Med       Date:  2019-10-07       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.